Generics - Generics, Europe

Filter

Current filters:

GenericsEurope

Popular Filters

1 to 25 of 30 results

European generics group launches Code of Conduct

05-03-2015

Following the adoption of the European Commission Guiding Principles Promoting Good Governance in the…

BiosimilarsEuropeGenericsMarkets & MarketingRegulation

Opportunities, challenges, strategies and forecasts for generic drugs market; report

Opportunities, challenges, strategies and forecasts for generic drugs market; report

23-02-2015

Already prevalent in the USA, Europe and much of the developing world, generic drugs are now finding…

BiosimilarsEuropeGenericsGlobalMarkets & Marketing

European Commission clears Mylan acquisition of Abbott's European generics business

European Commission clears Mylan acquisition of Abbott's European generics business

29-01-2015

The European Commission has cleared the proposed acquisition of Abbott Laboratories’ non-US developed…

Abbott LaboratoriesEuropeGenericsMergers & AcquisitionsMylan

EMA to boost international cooperation on generics

EMA to boost international cooperation on generics

19-01-2015

The European Medicines Agency is ready to share its assessments of applications for generic medicines…

EuropeGenericsGlobalRegulation

AMRI to develop parenteral drug products with Genovi

13-01-2015

Albany Molecular Research has entered into several development and supply agreements with the UK’s…

Albany Molecular ResearchEuropeGenericsGenovi PharmaceuticalsMarkets & MarketingProductionUSA

Europe’s research and generic/biosimilar industries join forces against counterfeiting

Europe’s research and generic/biosimilar industries join forces against counterfeiting

09-12-2014

Trade groups the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European…

ESMEuropeGenericsMarkets & MarketingPharmaceutical

Cipla links with SII for affordable pediatric vaccines in Europe

20-11-2014

The European subsidiary of Indian drugmaker Cipla has entered a distribution agreement with Serum Institute…

CiplaEuropeGenericsMarkets & MarketingSerum Institute of IndiaVaccines

Opportunity to promote good antibiotics prescription practices, says EGA

19-11-2014

The European Generic medicines Association (EGA) used the platform of European Antibiotic Awareness Day…

Antibiotics and Infectious diseasesEuropeGenericsMarkets & MarketingPricing

EGA and EBG see EMA latest biosimilars guidance as “important step forward”

EGA and EBG see EMA latest biosimilars guidance as “important step forward”

04-11-2014

The European Generic medicines Association (EGA) and the European Biosimilars Group (EBG), a sector group…

BiosimilarsEuropeGenericsRegulation

Update: Negotiations on EU-Canada Free Trade Agreement concluded

Update: Negotiations on EU-Canada Free Trade Agreement concluded

29-09-2014

Canadian trade group Research-Based Pharmaceutical Companies (Rx&D) expressed its support to the government…

CanadaEuropeGenericsMarkets & MarketingPatentsPoliticsRegulation

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

02-09-2014

UK-based Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory…

EuropeEvohalerFinancialFluticasone PropionateGenericsGlaxoSmithKlineMylanProsonixRegulationRespiratory and Pulmonary

Europe to boost cooperation with international partners on generics

Europe to boost cooperation with international partners on generics

08-08-2014

The European Union’s decentralized procedure is being used as a model to accelerate the assessment…

EuropeEuropean UnionGenericsGlobalRegulation

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

European Generic Medicines Association speaks out against EC’s perindopril decision

European Generic Medicines Association speaks out against EC’s perindopril decision

09-07-2014

The European Generic Medicines Association (EGA) has expressed concerns over the European Commission’s…

Cardio-vascularEuropeGenericsLegalLupinperindoprilServierunichem

Australia’s TGA joins EDQM's CEP assessment process

Australia’s TGA joins EDQM's CEP assessment process

17-06-2014

The Australian Therapeutic Goods Administration (TGA) is set to strengthen its collaboration with the…

AustraliaEuropeGenericsRegulation

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

05-06-2014

European regulatory authorities have finalized their assessment of reported non-compliance with Good…

EuropeGenericsIndiaProductionRanbaxy LaboratoriesRegulation

European and Japanese generics groups view opportunities on biosimilars

European and Japanese generics groups view opportunities on biosimilars

29-05-2014

The European Generic Medicines Association (EGA) participated in several meetings with Japanese government…

BiosimilarsEuropeGenericsJapanMarkets & MarketingRegulation

Grunenthal strengthens pain product portfolio with European rights to etoricoxib

07-05-2014

Family-owned German drugmaker Grunenthal Group today announced the signing of an exclusive promotion…

etoricoxibEuropeGenericsGrunenthalLicensingMerck & CoNeurological

EU approval for Teva’s DuoResp Spiromax for asthma and COPD

EU approval for Teva’s DuoResp Spiromax for asthma and COPD

30-04-2014

The European Commission has granted marketing authorization for Israel-based Teva Pharmaceutical Industries’…

DuoResp SpiromaxEuropeGenericsRegulationRespiratory and PulmonaryTeva Pharmaceutical Industries

EGA president seeks partnership with Italian government on generics and biosimilars

09-04-2014

The president of the European Generic Medicines Association (EGA), Nick Haggar, attended the Stati Generali…

BiosimilarsEuropeGenericsItalyMarkets & MarketingPolitics

US/EU generic industries call for thoughtful changes to speed medicines to patients

US/EU generic industries call for thoughtful changes to speed medicines to patients

08-04-2014

In a joint letter sent to the European Commission and the Office of the US Trade Representative, the…

EuropeGenericsPoliticsRegulationUSA

European generic drug makers sets out priorities for EU Trade Policy

European generic drug makers sets out priorities for EU Trade Policy

02-04-2014

European Generic Medicines Association (EGA) revealed this morning that its president, Nick Haggar, has…

EuropeGenericsPoliticsRegulationRest of the World

1 to 25 of 30 results

Back to top